Join the Fight Against MDS
Every gift helps patients, caregivers, and healthcare professionals access life-saving resources, support, and education. Together, we can make a difference. Even a small contribution can create a big impact. Thank you for your generosity.
June 13, 2020
Treatment of High Risk MDS and the Indication for Stem Cell Transplant
Treatment of High Risk MDS and the Indication for Stem Cell Transplant
This webinar will provide an overview of high-risk MDS, secondary AML, and indication for stem cell transplant, focusing on strategies for patient management. Risk assessment, treatment options, as well as resources for patients and caregivers will be discussed.
Speaker
Prapti Patel, MD
Outputs
Access to the meeting outputs are available below by clicking on each topic.
Our Supporters
Thank you to Bristol-Myers Squibb, Novartis, Jazz Pharmaceuticals, Takeda Oncology, and Acceleron for supporting this initiative.
